Effects of Clobazam on Sleep and Daytime Function in Patients With Epilepsy
Completed
Conditions studied: Epilepsy
In brief
The purpose of this study is to monitor the effect of Clobazam on sleep and daytime alertness in people with Epilepsy.
Key facts
- Study ID
- NCT02911025
- Run by
- Brigham and Women's Hospital
- People needed
- 13
- Starts
- 2015-01-01
- Expected to finish
- 2017-12-01
- Last updated by the study team
- 2021-02-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- adults aged 18 years or older
- diagnosis of epilepsy who are being considered for treatment with Clobazam
You may not qualify if…
- known untreated moderate or severe sleep apnea
- major circadian rhythm disorders
Where it is running
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Brigham and Women's Faulkner Hospital — Jamaica Plain, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.